Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Important Note: The FDA has not approved BPC-157 for any medical condition, and it is classified as an experimental, unapproved new drug
Documentation Every Reputable Vendor Should Provide Minimum documentation for a KLOW purchase should include: (1) product specification sheet confirming the 50/10/10/10mg ratio and 3mL volume
Australia's TGA has scheduled BPC-157 as Schedule 9 (Prohibited Substance) effective July 1, 2026
Living with a complex, invisible illness like Long COVID, ME/CFS, or dysautonomia is an incredibly challenging journey
Just like anything, too much of a good thing can cause major problems, and this includes effects on our normal physiology
H.ChengA
US$ 24.75
US$ 27.48
US$ 20.16
